Mangione's lawyers reverse course on psychiatric defence in state murder trial

Luigi Mangione's defense attorneys have withdrawn their intention to pursue a psychiatric defense in his state murder trial. This reversal occurred a day after they informed the judge they would argue Mangione suffered from "extreme emotional disturbance" at the time of the fatal shooting of Brian Thompson, CEO of UnitedHealthcare, in midtown Manhattan. The defense team's change of strategy came just before a deadline to provide supporting information for the psychiatric defense. Had they proceeded and been successful, this defense could have potentially led to a manslaughter conviction instead of murder, resulting in a shorter prison sentence. Mangione has pleaded not guilty in both the federal and state cases.

Luigi Mangione's legal team has withdrawn their intention to pursue an "extreme emotional disturbance" defense in his upcoming state trial for the killing of UnitedHealthcare CEO Brian Thompson. This reversal occurred just one day after informing the judge of their plan to use this defense, which could have led to a manslaughter conviction instead of murder. The defense team faced a deadline to provide supporting information for the claim. Mangione has pleaded not guilty to state and federal charges, with his state trial scheduled for September 8 and his federal trial for stalking charges on October 13. Thompson was shot and killed in December 2024 as he walked to a Manhattan hotel.

Luigi Mangione's lawyers intend to present a psychiatric defense in his state murder trial for the killing of UnitedHealthcare CEO Brian Thompson. They will argue that Mangione was experiencing "extreme emotional disturbance" at the time of the incident. This defense, if accepted by a jury, could lead to a manslaughter conviction instead of murder. Court records related to this defense plan will be unsealed. Mangione has pleaded not guilty to both state and federal charges, including federal stalking charges. His state trial is scheduled to commence on September 8th.

Luigi Mangione, accused of fatally shooting United Healthcare CEO Brian Thompson in New York City in December 2024, will use a psychiatric defense during his trial. His lawyers informed the judge they will argue Mangione was in a state of "extreme emotional disturbance" at the time of the alleged shooting. This defense, permitted under New York law, could lead to a manslaughter conviction instead of murder, resulting in a lighter sentence. The article notes that the terms "delay," "deny," and "depose" were found on Mangione's ammunition, potentially referencing anger towards health insurance companies. This plea admits to the act but claims impaired judgment, differing from an insanity defense.

Luigi Mangione will assert a psychiatric defense in the state murder trial for the killing of UnitedHealthcare CEO Brian Thompson. His lawyers informed Judge Gregory Carro they will argue Mangione was suffering from "extreme emotional disturbance" at the time of the killing. This defense admits Mangione killed Thompson but claims mitigating circumstances, potentially leading to a manslaughter conviction instead of murder, resulting in a lesser sentence. The judge will unseal records related to the defense's decision, which was made after a secret hearing. Mangione has pleaded not guilty to state and federal charges, with his federal trial for stalking charges set for October.